- Home
- Products
- Customized FluoroAb™
- FLAG
- Anti-FLAG MAb (Clone 3)-iFluor® 460 Succinimidyl Ester
Anti-FLAG MAb (Clone 3)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8756)
This product is comprised of an Chimeric Anti-FLAG IgG1-kappa (Clone 3) labeled with iFluor® 460 Succinimidyl Ester. iFluor® 460 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- FLAG
- Overview
- Chimeric Anti-FLAG IgG1-kappa (Clone 3)
- Species Reactivity
- Human
- Name
- iFluor® 460 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 468/493
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS8756. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-585 | Anti-FLAG-SPDP-NCS ADC | SPDP(N-succinimidyl 3-[2-pyridyldithio]-propionate) | NCS |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MSLN MAb (Clone 4)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14317)
- Anti-MET MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2195)
- Anti-CD2 MAb (Clone 14)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8801)
- Anti-IL22 MAb (Clone 3)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10556)
- Anti-CD3E MAb (Clone 19)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10364)
- Anti-CD40 MAb (Clone 7)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8867)
- Anti-SLC34A2 MAb (Clone 3)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8738)
- Anti-CTLA4 MAb (Clone 15)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12013)
- Anti-IGF1 MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6760)
- Anti-ICAM1 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8294)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.